Skip to main content

Advertisement

SpringerLink
Log in

Urticaria and Angioedema: an Update on Classification and Pathogenesis

  • Published:
Clinical Reviews in Allergy & Immunology Aims and scope Submit manuscript

Abstract

Urticaria is a common, mast cell-driven disease presenting with wheals or angioedema or both. In the last years, urticaria has increasingly attracted notice to clinicians and researchers, last but not least inspired by the approval of omalizumab, an anti-IgE antibody, for urticaria treatment. There is wide consensus on the clinical classification based on duration and elicitation. However, the pathogenesis is incompletely understood. This review summarizes current guidelines for the management and novel insights in the pathogenesis of urticaria with special focus on their impact on clinical praxis. The classification of urticaria subgroups is mainly based on clinical criteria: acute and chronic urticaria (CU). Chronic urticaria comprises both chronic spontaneous urticaria (CSU) and chronic inducible urticaria (CIndU) that includes physical and non-physical urticarias. Recent research focused on characterizing the role of cells and mediators involved in the pathogenesis of urticaria, identifying the mechanisms of mast cell activation, and investigating underlying autoimmune processes in chronic spontaneous urticarial. Currently, non-sedating antihistamines and omalizumab, an antiimmunoglobulin E antibody, are recommended for the therapy of chronic urticaria, as both exhibit a favorable efficacy and safety profile. Novel therapeutic strategies aim at specifically targeting cells and mediators involved in the pathogenesis of urticaria.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

ACE:

Angiotensin converting enzyme

ACU:

Acquired cold urticaria

AE:

Angioedema

AIU:

Autoimmune urticaria

ASST:

Autologous serum skin test

ChU:

Cholinergic urticaria

CIndU:

Chronic indicible urticaria

CRTH2:

Chemoattractant receptor–homologous molecule expressed on TH2 cells

CU:

Chronic urticaria

CSU:

Chronic spontaneous urticaria

DPU:

Delayed pressure urticaria

Ig:

Immunoglobuline

IL:

Interleukin

PG:

Prostaglandin

SU:

Solar urticaria

TNF:

Tumor necrosis factor

TPO:

Thyroperoxidase

UAS:

Urticaria activity score

References

  1. Fine LM, Bernstein JA (2016) Guideline of chronic urticaria beyond. Allergy Asthma Immunol Res 8:396–403. doi:10.4168/aair.2016.8.5.396

    Article  PubMed  PubMed Central  Google Scholar 

  2. Zuberbier T, Aberer W, Asero R, Bindslev-Jensen C et al (2014) The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy 69:868–887. doi:10.1111/all.12313

    Article  CAS  PubMed  Google Scholar 

  3. Wu MA, Perego F, Zanichelli A et al (2016) Angioedema phenotypes: disease expression and classification. Clinic Rev Allerg Immunol 51:162. doi:10.1007/s12016-016-8541-z

    Article  CAS  Google Scholar 

  4. Magerl M, Altrichter S, Borzova E, Giménez-Arnau A, Grattan CE, Lawlor F, Mathelier-Fusade P, Meshkova RY, Zuberbier T, Metz M, Maurer M (2016) The definition, diagnostic testing, and management of chronic inducible urticarias—the EAACI/GA(2) LEN/EDF/UNEV consensus recommendations 2016 update and revision. Allergy 71:780–802. doi:10.1111/all.12884

    Article  CAS  PubMed  Google Scholar 

  5. Weller K, Maurer M, Grattan C, Nakonechna A, Abuzakouk M, Bérard F, Sussman G, Giménez-Arnau AM, Ortiz de Frutos J, Knulst A, Canonica GW, Hollis K, McBride D, Balp MM (2015) ASSURE-CSU: a real-world study of burden of disease in patients with symptomatic chronic spontaneous urticaria. Clin Transl Allergy 5:29. doi:10.1186/s13601-015-0072-9

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. Doong JC, Chichester K, Oliver ET, Schwartz LB, Saini SS (2017) Chronic idiopathic urticaria: systemic complaints and their relationship with disease and immune measures. J Allergy Clin Immunol Pract Epub ahead of print doi. doi:10.1016/j.jaip.2016.11.037

  7. Lapi F, Cassano N, Pegoraro V, Cataldo N, Heiman F, Cricelli I, Levi M, Colombo D, Zagni E, Cricelli C, Vena GA (2016) Epidemiology of chronic spontaneous urticaria: results from a nationwide, population-based study in Italy. Br J Dermatol 174:996–1004. doi:10.1111/bjd.14470

    Article  CAS  PubMed  Google Scholar 

  8. Sánchez J, Amaya E, Acevedo A, Celis A, Caraballo D, Cardona R (2017) Prevalence of inducible urticaria in patients with chronic spontaneous urticaria: associated risk factors. J Allergy Clin Immunol Pract 5:464–470. doi:10.1016/j.jaip.2016.09.029

    Article  PubMed  Google Scholar 

  9. Kolkhir P, Church MK, Weller K, Metz M, Schmetzer O, Maurer M (2016) Autoimmune chronic spontaneous urticaria: what we know and what we do not know. J Allergy Clin Immunol Epub ahead of print doi. doi:10.1016/j.jaci.2016.08.050

  10. Konstantinou GN, Asero R, Ferrer M, Knol EF, Maurer M, Raap U, Schmid-Grendelmeier P, Skov PS, Grattan CE (2013) EAACI taskforce position paper: evidence for autoimmune urticaria and proposal for defining diagnostic criteria. Allergy 68:27–36. doi:10.1111/all.12056

    Article  CAS  PubMed  Google Scholar 

  11. Dice JP (2004) Physical urticaria. Immunol Allergy Clin N Am 24:225–246

    Article  Google Scholar 

  12. TaÍkapan O, Harmanyeri Y (2006) Evaluation of patients with symptomatic dermographism. JEADV 20:58–62

    Google Scholar 

  13. Mlynek A, Vieira dos Santos R, Ardelean E, Weller K, Magerl M, Church MK, Maurer M (2013) A novel, simple, validated and reproducible instrument for assessing provocation threshold levels in patients with symptomatic dermographism. Clin Exp Dermatol 38:360–366. doi:10.1111/ced.12107

    Article  CAS  PubMed  Google Scholar 

  14. Martinez-Escala ME, Curto-Barredo L, Carnero L, Pujol RM, Gimenez-Arnau AM (2015) Temperature thresholds in assessment of the clinical course of acquired cold contact urticaria: a retrospective observational one year study. Acta Derm Venereol 95:278–282. doi:10.2340/00015555-1918

    Article  PubMed  Google Scholar 

  15. Alangari AA, Twarog FJ, Shih MC et al (2004) Clinical features and anaphylaxis in children with cold urticaria. Pediatrics 113:e313–e317

    Article  PubMed  Google Scholar 

  16. Siebenhaar F, Weller K, Mlynek A, Magerl M, Altrichter S, Vieira dos Santos R, Maurer M, Zuberbier T (2007) Acquired cold urticaria: clinical picture and update on diagnosis and treatment. Clin Exp Dermatol 32:241–245

    Article  CAS  PubMed  Google Scholar 

  17. Wanderer AA, Hoffman HM (2004) The spectrum of acquired and familial cold induced urticaria/urticaria-like syndromes. Immunol Allergy Clin N Am 24:259–286

    Article  Google Scholar 

  18. Abajian M, Schoepke N, Altrichter S, Zuberbier T, Maurer M (2014) Physical urticarias and cholinergic urticaria. Immunol Allergy Clin N Am 34:73–88. doi:10.1016/j.iac.2013.09.010

    Article  Google Scholar 

  19. Du-Thanh A, Debu A, Lalheve P et al (2013) Solar urticaria: a time-extended retrospective series of 61 patients and review of literature. Eur J Dermatol 23:202–207. doi:10.1684/ejd.2013.1933

    PubMed  Google Scholar 

  20. Horio T (1978) Photoallergic urticaria induced by visible light. Additional cases and further studies. Arch Dermatol 114:1761–1764

    Article  CAS  PubMed  Google Scholar 

  21. Duchini G, Baumler W, Bircher AJ, Scherer K (2011) Failure of omalizumab (Xolair®) in the treatment of a case of solar urticaria caused by ultraviolet A and visible light. Photodermatol Photoimmunol Photomed 27:336–337. doi:10.1111/j.1600-0781.2011.00624.x

    Article  CAS  PubMed  Google Scholar 

  22. Terrani I, Bircher AJ, Scherer Hofmeier K (2016) Solar urticaria induced by visible light: successful treatment with omalizumab. Clin Exp Dermatol 41:890–892. doi:10.1111/ced.12951

    Article  CAS  PubMed  Google Scholar 

  23. Zuberbier T, Althaus C, Chatraine-Hess S et al (1994) Prevalence of cholinergic urticaria in young adults. J Am Acad Dermatol 31:978–981

    Article  CAS  PubMed  Google Scholar 

  24. Ramam M, Pahwa P (2012) Is cholincergic urticaria a seasonal disorder in some patients? Indian J Dermatol Venereol Leprol 78:190–191. doi:10.4103/0378-6323.93641

    Article  CAS  PubMed  Google Scholar 

  25. Takahagi S, Tanaka T, Ishii K et al (2009) Sweat antigen induces histamine release form basophils of patients with cholinergic uticaria associated with atopic diathesis. Br J Dermatol 160:426–428. doi:10.1111/j.1365-2133.2008.08862.x

    Article  CAS  PubMed  Google Scholar 

  26. Petalas K, Kontou-Fili K, Gratziou C (2009) Bronchial hyperresponsiveness in patients with cholinergic urticaria. Ann Allergy Asthma Immunol 102:416–421. doi:10.1016/S1081-1206(10)60514-5

    Article  PubMed  Google Scholar 

  27. Sawada Y, Nakamura M, Bito T, Sakabe J, Kabashima-Kubo R, Hino R, Kobayashi M, Tokura Y (2014) Decreased expression of acetylcholine esterase in cholinergic urticaria with hypohidrosis or anhidrosis. J Invest Dermatol 134:276–279. doi:10.1038/jid.2013.244

    Article  CAS  PubMed  Google Scholar 

  28. Fukunaga A, Washio K, Hatakeyama M, Oda Y, Ogura K, Horikawa T, Nishigori C (2017) Cholinergic urticaria: epidemiology, physiopathology, new categorization, and management. Clin Auton Res Epub ahead of print doi. doi:10.1007/s10286-017-0418-6

  29. Horikawa T, Fukunaga A, Nishigori C (2009) New concepts of hive formation in cholinergic urticaria. Curr Allergy Asthma Rep 9:273–279

    Article  PubMed  Google Scholar 

  30. Bito T, Sawada Y, Tokura Y (2012) Pathogenesis of cholinergic urticaria in relation to sweating. Allergol Int 61:539–544. doi:10.2332/allergolint.12-RAI-0485

    Article  CAS  PubMed  Google Scholar 

  31. Fukunaga A, Hatakeyama M, Tsujimoto M, Oda Y, Washio K, Nishigori C (2015) Steroid treatment can improve the impaired quality of life of patients with acquired idiopathic generalized anhidrosis. Br J Dermatol 172:537–538. doi:10.1111/bjd.13285

    Article  CAS  PubMed  Google Scholar 

  32. Kalathoor I (2015) Snoring-induced vibratory angioedema. Am J Case Rep 16:700-702. doi: 10.12659/AJCR.894636

  33. Aloyouny A, Stoopler ET (2016) Vibrational angioedema: considerations for oral health care providers. Spec Care Dentist 36:335–338. doi:10.1111/scd.12185

    Article  PubMed  Google Scholar 

  34. Boyden SE, Desai A, Cruse G, Young ML, Bolan HC, Scott LM, Eisch AR, Long RD, Lee CC, Satorius CL, Pakstis AJ, Olivera A, Mullikin JC, Chouery E, Mégarbané A, Medlej-Hashim M, Kidd KK, Kastner DL, Metcalfe DD, Komarow HD (2016) Vibratory urticaria associated with a missense variant in ADGRE2. N Engl J Med 374:656–663. doi:10.1056/NEJMc1604757

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Zuberbier T (2003) Urticaria. Allergy 58:1224–1234

    Article  CAS  PubMed  Google Scholar 

  36. Wedi B, Kapp A (2006) Current position of the role of allergic and non-allergic food hypersensitivity in urticaria. Hautarzt 57:101–107

    Article  CAS  PubMed  Google Scholar 

  37. Williams JD, Lee AY, Matheson MC, Frowen KE, Moonan AM, Nixon RL (2008) Occupational contact urticaria: Australian data. Br J Dermatol 159:125–131. doi:10.1111/j.1365-2133.2008.08583.x

    Article  CAS  PubMed  Google Scholar 

  38. Rothbaum R, McGee JS (2016) Aquagenic urticaria: diagnostic and management challenges. J Asthma Allergy 9:209–213

    Article  PubMed  PubMed Central  Google Scholar 

  39. Kulthanan K, Chiawsirikajorn Y, Jiamton S (2008) Acute urticaria: etiologies, clinical course and quality of life. Asian Pac J Allergy Immunol 26:1–9

    PubMed  Google Scholar 

  40. Zelić SB, Rubeša G, Brajac I, Peitl MV, Pavlović E (2016) Satisfaction with life and coping skills in the acute and chronic urticaria. Psychiatr Danub 28:34–38

    PubMed  Google Scholar 

  41. Dias GA, Pires GV, Valle SO, Dortas SD Júnior, Levy S, França AT, Baiardini I, Canonica WG (2016) Impact of chronic urticaria on the quality of life of patients followed up at a university hospital. An Bras Dermatol 91:754–759. doi: 10.1590/abd1806-4841.20165071

  42. Mendelson MH, Bernstein JA, Gabriel A, Balp MM, Tian H, Vietri J, Lebwohl M (2016) Patient-reported impact of chronic urticaria compared with psoriasis in the United States. J Dermatol Treat Epub ahead of print. doi:10.1080/09546634.2016.1227421

  43. Mlynek A, Zalewska-Janowska A, Martus P, Staubach P, Zuberbier T, Maurer M (2008) How to assess disease activity in patients with chronic urticaria? Allergy 63:777–780. doi:10.1111/j.1398-9995.2008.01726.x

    Article  CAS  PubMed  Google Scholar 

  44. Baiardini I, Braido F, Bindslev-Jensen C, Bousquet PJ et al (2011) Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA2LEN taskforce position paper. Allergy 66:840–844. doi:10.1111/j.1398-9995.2011.02580.x

    Article  CAS  PubMed  Google Scholar 

  45. Mathias SD, Dreskin SC, Kaplan A, Saini SS, Spector S, Rosen KE (2010) Development of a daily diary for patients with chronic idiopathic urticaria. Ann Allergy Asthma Immunol 105:142–148. doi:10.1016/j.anai.2010.06.011

    Article  PubMed  Google Scholar 

  46. Stull D, McBride D, Tian H, Gimenez Arnau A, Maurer M, Marsland A, Balp MM, Khalil S, Grattan C (2017) Analysis of disease activity categories in chronic spontaneous/idiopathic urticaria. Br J Dermatol Epub ahead of print. doi:10.1111/bjd.15454

  47. Staubach P (2007) Differential diagnosis of urticaria. Hautarzt 58:314–317

    Article  CAS  PubMed  Google Scholar 

  48. Jachiet M, Flageul B, Deroux A, Le Quellec A, Maurier F, Cordoliani F, Godmer P, Abasq C, Astudillo L, Belenotti P, Bessis D, Bigot A, Doutre MS, Ebbo M, Guichard I, Hachulla E, Héron E, Jeudy G, Jourde-Chiche N, Jullien D, Lavigne C, Machet L, Macher MA, Martel C, Melboucy-Belkhir S, Morice C, Petit A, Simorre B, Zenone T, Bouillet L, Bagot M, Frémeaux-Bacchi V, Guillevin L, Mouthon L, Dupin N, Aractingi S, Terrier B, French Vasculitis Study Group (2015) The clinical spectrum and therapeutic management of hypocomplementemic urticarial vasculitis: data from a French nationwide study of fifty-seven patients. Arthritis Rheumatol 67:527–534. doi:10.1002/art.38956

    Article  CAS  PubMed  Google Scholar 

  49. Feliciani C, Joly P, Jonkman MF, Zambruno G, Zillikens D, Ioannides D, Kowalewski C, Jedlickova H, Kárpáti S, Marinovic B, Mimouni D, Uzun S, Yayli S, Hertl M, Borradori L (2015) Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology. Br J Dermatol 172:867–877. doi:10.1111/bjd.13717

    Article  CAS  PubMed  Google Scholar 

  50. Kolkhir P, Pogorelov D, Olisova O, Maurer M (2016) Comorbidity and pathogenic links of chronic spontaneous urticaria and systemic lupus erythematosus—a systematic review. Clin Exp Allergy 46:275–287. doi:10.1111/cea.12673

    Article  CAS  PubMed  Google Scholar 

  51. Confino-Cohen R, Chodick G, Shalev V, Leshno M, Kimhi O, Goldberg A (2012) Chronic urticaria and autoimmunity: associations found in a large population study. J Allergy Clin Immunol 129:1307–1313. doi:10.1016/j.jaci.2012.01.043

    Article  PubMed  Google Scholar 

  52. Wekell P, Karlsson A, Berg S, Fasth A (2016) Review of autoinflammatory diseases, with a special focus on periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome. Acta Paediatr 105:1140–1151. doi:10.1111/apa.13531

    Article  PubMed  PubMed Central  Google Scholar 

  53. Kastner DL, Aksentijevich I, Goldbach-Mansky R (2010) Autoinflammatory disease reloaded: a clinical perspective. Cell 140:784–790. doi:10.1016/j.cell.2010.03.002

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Krause K, Grattan CE, Bindslev-Jensen C, Gattorno M, Kallinich T, de Koning HD, Lachmann HJ, Lipsker D, Navarini AA, Simon A, Traidl-Hoffmann C, Maurer M (2012) How not to miss autoinflammatory diseases masquerading as urticaria. Allergy 67:1465–1474. doi:10.1111/all.12030

    Article  CAS  PubMed  Google Scholar 

  55. Kuemmerle-Deschner JB, Ozen S, Tyrrell PN, et al. (2016) Diagnostic criteria for cryopyrin-associated periodic syndrome (CAPS) Ann Rheum Dis. Oct 4. doi: 10.1136/annrheumdis-2016-209686

  56. Gusdorf L, Asli B, Barbarot S, Néel A, Masseau A, Puéchal X, Gottenberg JE, Grateau G, Blanchard-Delaunay C, Rizzi R, Lifermann F, Kyndt X, Aubin F, Bessis D, Boye T, Gayet S, Rongioletti F, Sauleau E, Fermand JP, Lipsker D (2017) Schnitzler syndrome: validation and applicability of diagnostic criteria in real-life patients. Allergy 72:177–182. doi:10.1111/all.13035

    Article  CAS  PubMed  Google Scholar 

  57. Navarini AA, Satoh TK, French LE (2016) Neutrophilic dermatoses and autoinflammatory diseases with skin involvement—innate immune disorders. Semin Immunopathol 38:45–56. doi:10.1007/s00281-015-0549-6

    Article  CAS  PubMed  Google Scholar 

  58. Webb K, Hlela C, Jordaan HF, Suliman S, Scriba T, Lipsker D, Scott C (2015) A review and proposed approach to the neutrophilic dermatoses of childhood. Pediatr Dermatol 32:437–446. doi:10.1111/pde.12502

    Article  PubMed  Google Scholar 

  59. de Graauw E, Beltraminelli H, Simon HU, Simon D (2015) Eosinophilia in dermatologic disorders. Immunol Allergy Clin N Am 35:545–560. doi:10.1016/j.iac.2015.05.005

    Article  Google Scholar 

  60. Landolt B, Staubli G, Lips U, Weibel L (2013) Skin disorders encountered in a Swiss pediatric emergency department. Swiss Med Wkly 143:w13731. doi:10.4414/smw.2013.13731

    PubMed  Google Scholar 

  61. Demoly P, Adkinson NF, Brockow K, Castells M, Chiriac AM, Greenberger PA, Khan DA, Lang DM, Park HS, Pichler W, Sanchez-Borges M, Shiohara T, Thong BY (2014) International consensus on drug allergy. Allergy 69:420–437. doi:10.1111/all.12350

    Article  CAS  PubMed  Google Scholar 

  62. Taylor D, Pappo E, Aronson IK (2016) Polymorphic eruption of pregnancy. Clin Dermatol 34:383–391. doi:10.1016/j.clindermatol.2016.02.011

    Article  PubMed  Google Scholar 

  63. Bork K (2014) Angioedema. Immunol Allergy Clin N Am 34:23–31. doi:10.1016/j.iac.2013.09.004

    Article  Google Scholar 

  64. Beltrami L, Zanichelli A, Zingale L, Vacchini R, Carugo S, Cicardi M (2011) Long-term follow-up of 111 patients with angiotensin-converting enzyme inhibitor-related angioedema. J Hypertens 29:2273–2277. doi:10.1097/HJH.0b013e32834b4b9b

    Article  CAS  PubMed  Google Scholar 

  65. Simons FE, Ebisawa M, Sanchez-Borges M, Thong BY, Worm M, Tanno LK, Lockey RF, El-Gamal YM, Brown SG, Park HS, Sheikh A (2015) 2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines. World Allergy Organ J 8:32. doi:10.1186/s40413-015-0080-1

    Article  PubMed  PubMed Central  Google Scholar 

  66. Renaudin JM, Beaudouin E, Ponvert C, Demoly P, Moneret-Vautrin DA (2013) Severe drug-induced anaphylaxis: analysis of 333 cases recorded by the Allergy Vigilance Network from 2002 to 2010. Allergy 68:929–937. doi:10.1111/all.12168

    Article  CAS  PubMed  Google Scholar 

  67. Kowalski ML, Woessner K, Sanak M. (2015) Approaches to the diagnosis and management of patients with a history of nonsteroidal anti-inflammatory drug-related urticaria and angioedema. J Allergy Clin Immunol 136:245–251. doi: 10.1016/j.jaci.2015.06.021

  68. Valent P, Akin C, Hartmann K, Nilsson G et al (2017) Advances in the classification and treatment of mastocytosis: current status and outlook toward the future. Cancer Res 77:1261–1270. doi:10.1158/0008-5472

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Maurer M, Church MK, Marsland AM, Sussman G, Siebenhaar F, Vestergaard C, Broom B (2016) Questions and answers in chronic urticaria: where do we stand and where do we go? J Eur Acad Dermatol Venereol 30:7–15. doi:10.1111/jdv.13695

    Article  PubMed  Google Scholar 

  70. Wernersson S, Pejler G (2014) Mast cell secretory granules: armed for battle. Nat Rev Immunol 14:478–494. doi:10.1038/nri3690

    Article  CAS  PubMed  Google Scholar 

  71. Kaplan AP, Horáková Z, Katz SI (1978) Assessment of tissue fluid histamine levels in patients with urticaria. J Allergy Clin Immunol 61:350–354. doi:10.1016/0091-6749(78)90113-6

    Article  CAS  PubMed  Google Scholar 

  72. Hong GU, Ro JY, Bae Y, Kwon IH, Park GH, Choi YH, Choi JH (2016) Association of TG2 from mast cells and chronic spontaneous urticaria pathogenesis. Ann Allergy Asthma Immunol 117:290–297. doi:10.1016/j.anai.2016.06.026

    Article  CAS  PubMed  Google Scholar 

  73. Kay AB, Clark P, Maurer M, Ying S (2015) Elevations in T-helper-2-initiating cytokines (interleukin-33, interleukin-25 and thymic stromal lymphopoietin) in lesional skin from chronic spontaneous (‘idiopathic’) urticaria. Br J Dermatol 172:1294–1302. doi:10.1111/bjd.13621

    Article  CAS  PubMed  Google Scholar 

  74. Ying S, Kikuchi Y, Meng Q, Kay AB, Kaplan AP (2002) TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction. J Allergy Clin Immunol 109:694–700

    Article  CAS  PubMed  Google Scholar 

  75. Altrichter S, Koch K, Church MK, Maurer M (2016) Atopic predisposition in cholinergic urticaria patients and its implications. J Eur Acad Dermatol Venereol 30:2060–2065. doi:10.1111/jdv.13765

    Article  CAS  PubMed  Google Scholar 

  76. Tedeschi A, Asero R, Marzano AV et al (2009) Plasma levels and skin-eosinophil-expression of vascular endothelial growth factor in patients with chronic urticaria. Allergy 64:1616–1622. doi:10.1111/j.1398-9995.2009.02069.x

    Article  CAS  PubMed  Google Scholar 

  77. Tedeschi A, Asero R, Lorini M et al (2010) Plasma levels of matrix metalloproteinase-9 in chronic urticaria patients correlate with disease severity and C-reactive protein but not with circulating histamine-releasing factors. Clin Exp Allergy 40:875–881. doi:10.1111/j.1365-2222.2010.03473.x

    Article  CAS  PubMed  Google Scholar 

  78. Kasperska-Zajac A, Sztylc J, Machura E et al (2011) Plasma IL-6 concentration correlates with clinical disease activity and serum C-reactive protein concentration in chronic urticaria patients. Clin Exp Allergy 41:1386–1391. doi:10.1111/j.1365-2222.2011.03789.x

    Article  CAS  PubMed  Google Scholar 

  79. Kaplan AP, Giménez-Arnau AM, Saini SS (2017) Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticarial. Allergy 72:519–533. doi:10.1111/all.13083

    Article  CAS  PubMed  Google Scholar 

  80. Oliver ET, Sterba PM, Saini SS (2015) Interval shifts in basophil measures correlate with disease activity in chronic spontaneous urticaria. Allergy 70:601–603. doi:10.1111/all.12578

    Article  CAS  PubMed  Google Scholar 

  81. Oliver ET, Sterba PM, Devine K, Vonakis BM, Saini SS (2016) Altered expression of chemoattractant receptor–homologous molecule expressed on TH2 cells on blood basophils and eosinophils in patients with chronic spontaneous urticaria. J Allergy Clin Immunol 137:304–306. doi:10.1016/j.jaci.2015.06.004

    Article  CAS  PubMed  Google Scholar 

  82. Raap U, Gehring M, Kleiner S, Rüdrich U, Eiz-Vesper B, Haas H, Kapp A, Gibbs BF (2017) Human basophils are differentially activated by and are a source of IL-31. Clin Exp Allergy 47:499–508. doi:10.1111/cea.12875

    Article  CAS  PubMed  Google Scholar 

  83. Chen Q, Zhai Z, Xu J, Chen W, Chen S, Zhong H, Huang X, Hao F, Song Z (2017) Basophil CD63 expression in chronic spontaneous urticaria: correlation with allergic sensitization, serum autoreactivity and basophil reactivity. J Eur Acad Dermatol Venereol 31:463–468. doi:10.1111/jdv.13912

    Article  PubMed  CAS  Google Scholar 

  84. Jain S (2014) Pathogenesis of chronic urticarial: an overview. Dermatol Res Pract 2014:674709.doi 10.1155/2014/674709

  85. Sterba PM, Hamilton RG, Saini SS (2015) Suppression of basophil FcεRI activation by serum from active chronic idiopathic/spontaneous urticaria (CIU/CSU) subjects. J Invest Dermatol 135:1454–1456. doi:10.1038/jid.2015.13

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Kay AB, Ying S, Ardelean E, Mlynek A, Kita H, Clark P, Maurer M (2014) Elevations in vascular markers and eosinophils in chronic spontaneous urticarial weals with low-level persistence in uninvolved skin. Br J Dermatol 171:505–511. doi:10.1111/cea.12348

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  87. Fujisawa D, Kashiwakura J, Kita H, Kikukawa Y, Fujitani Y, Sasaki-Sakamoto T, Kuroda K, Nunomura S, Hayama K, Terui T, Ra C, Okayama Y (2014) Expression of Mas-related gene X2 on mast cells is upregulated in the skin of patients with severe chronic urticaria. J Allergy Clin Immunol 134:622–633. doi:10.1016/j.jaci.2014.05.004

    Article  CAS  PubMed  Google Scholar 

  88. Cugno M, Marzano AV, Tedeschi A, Fanoni D, Venegoni L, Asero R (2009) Expression of tissue factor by eosinophils in patients with chronic urticaria. Int Arch Allergy Clin Immunol 148:170–174. doi:10.1159/000155748

    Article  CAS  Google Scholar 

  89. Fiebiger E, Maurer D, Holub H, Reininger B, Hartmann G, Woisetschläger M, Kinet JP, Stingl G (1995) Serum IgG autoantibodies directed against the alpha chain of Fc epsilon RI: a selective marker and pathogenetic factor for a distinct subset of chronic urticaria patients? J Clin Invest 96:2606–1262

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  90. Kikuchi Y, Kaplan AP (2002) A role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticaria. J Allergy Clin Immunol 109:114–118

    Article  CAS  PubMed  Google Scholar 

  91. Lu T, Jiao X, Si M, He P, Zou J, Zhang S, Zeng K (2016) The correlation of serums CCL11, CCL17, CCL26, and CCL27 and disease severity in patients with urticaria. Dis Markers 1381760. doi:10.1155/2016/1381760

  92. Vonakis BM, Vasagar K, Gibbons SP Jr, Gober L, Sterba PM, Chang H, Saini SS (2007) Basophil FcεRI histamine release parallels expression of Src-homology 2-containing inositol phosphatases in chronic idiopathic urticaria. J Allergy Clin Immunol 119:441–448

    Article  CAS  PubMed  Google Scholar 

  93. Ayuso P, Plaza-Serón Mdel C, Blanca-López N, Doña I, Campo P, Canto G, Laguna JJ, Bartra J, Soriano-Gomis V, Blanca M, Cornejo-García JA, Perkins JR (2015) Genetic variants in arachidonic acid pathway genes associated with NSAID-exacerbated respiratory disease. Pharmacogenomics 16:825–839. doi:10.2217/pgs.15.43

    Article  CAS  PubMed  Google Scholar 

  94. Asero R, Tedeschi A, Coppola R, Griffini S, Paparella P, Riboldi P, Marzano AV, Fanoni D, Cugno M (2007) Activation of the tissue factor pathway of blood coagulation in patients with chronic urticaria. J Allergy Clin Immunol 119:705–710

    Article  CAS  PubMed  Google Scholar 

  95. Asero R, Tedeschi A, Riboldi P, Griffini S, Bonanni E, Cugno M (2008) Severe chronic urticaria is associated with elevated plasma levels of D-dimer. Allergy 63:176–180

    CAS  PubMed  Google Scholar 

  96. Takahagi S, Mihara S, Iwamoto K, Morioke S, Okabe T, Kameyoshi Y, Hide M (2010) Coagulation/fibrinolysis and inflammation markers are associated with disease activity in patients with chronic urticaria. Allergy 65:649–656. doi:10.1111/j.1398-9995.2009.02222.x

    Article  CAS  PubMed  Google Scholar 

  97. Puccetti A, Bason C, Simeoni ME, Millo E, Tinazzi E, Beri R, Peterlana D, Zanoni G, Senna G, Corrocher R, Lunardi C (2005) In chronic idiopathic urticaria autoantibodies against Fc epsilonRII/CD23 induce histamine release via eosinophil activation. Clin Exp Allergy 35:1599–1607

    Article  CAS  PubMed  Google Scholar 

  98. Bossi F, Frossi B, Radillo O, Cugno M, Tedeschi A, Riboldi P, Asero R, Tedesco F, Pucillo C (2011) Mast cells are critically involved in serum-mediated vascular leakage in chronic urticaria beyond high-affinity IgE receptor stimulation. Allergy 66:1538–1545. doi:10.1111/j.1398-9995.2011.02704.x

    Article  CAS  PubMed  Google Scholar 

  99. Krause K, Giménez-Arnau A, Martinez-Escala E, Farré-Albadalejo M, Abajian M, Church MK, Maurer M (2013) Platelet-activating factor (PAF) induces wheal and flare skin reactions independent of mast cell degranulation. Allergy 68:256–258. doi:10.1111/all.12083

    Article  CAS  PubMed  Google Scholar 

  100. Tokura Y (2016) New etiology of cholinergic urticaria. Curr Probl Dermatol 51:94–100. doi:10.1159/000446787

    Article  PubMed  Google Scholar 

  101. Pan XF, Gu JQ, Shan ZY (2015) The prevalence of thyroid autoimmunity in patients with urticaria: a systematic review and meta-analysis. Endocrine 48:804–810. doi:10.1007/s12020-014-0367-y

    Article  CAS  PubMed  Google Scholar 

  102. Kikuchi Y, Fann T, Kaplan AP (2003) Antithyroid antibodies in chronic urticaria and angioedema. J Allergy Clin Immunol 112:218

    Article  PubMed  Google Scholar 

  103. Altrichter S, Peter HJ, Pisarevskaja D, Metz M, Martus P, Maurer M (2011) IgE mediated autoallergy against thyroid peroxidase—a novel pathomechanism of chronic spontaneous urticaria? PLoS One 6(4):e14794. doi:10.1371/journal.pone.0014794

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  104. Curth HM, Dinter J, Nigemeier K, Kütting F, Hunzelmann N, Steffen HM (2015) Effects of helicobacter pylori eradication in chronic spontaneous urticaria: results from a retrospective cohort study. Am J Clin Dermatol 16:553–558. doi:10.1007/s40257-015-0152-6

    Article  PubMed  Google Scholar 

  105. Dreyfus DH (2016) Serological evidence that activation of ubiquitous human herpesvirus-6 (HHV-6) plays a role in chronic idiopathic/spontaneous urticaria (CIU). Clin Exp Immunol 183:230–238. doi:10.1111/cei.12704

    Article  CAS  PubMed  Google Scholar 

  106. Kolkhir P, Balakirski G, Merk HF, Olisova O, Maurer M (2016) Chronic spontaneous urticaria and internal parasites—a systematic review. Allergy 71:308–322. doi:10.1111/all.12818

    Article  CAS  PubMed  Google Scholar 

  107. Bakker RA, Wieland K, Timmerman H, Leurs R (2000) Constitutive activity of the histamine H(1) receptor reveals inverse agonism of histamine H(1) receptor antagonists. Eur J Pharmacol 387:5–7

    Article  Google Scholar 

  108. Weller K, Ziege C, Staubach P, Brockow K, Siebenhaar F, Krause K, Altrichter S, Church MK, Maurer M (2011) H1-antihistamine up-dosing in chronic spontaneous urticaria: patients’ perspective of effectiveness and side effects—a retrospective survey study. PLoS One 6:e23931. doi:10.1371/journal.pone.0023931

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  109. Krause K, Spohr A, Zuberbier T, Church MK, Maurer M (2013) Up-dosing with bilastine results in improved effectiveness in cold contact urticaria. Allergy 68:921–928. doi:10.1111/all.12171

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  110. Staevska M, Gugutkova M, Lazarova C, Kralimarkova T, Dimitrov V, Zuberbier T, Church MK, Popov TA (2014) Night-time sedating H1-antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled trial. Br J Dermatol 171:148–154. doi:10.1111/bjd.12846

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  111. Maurer M, Rosén K, Hsieh HJ, Saini S, Grattan C, Gimenéz-Arnau A, Agarwal S, Doyle R, Canvin J, Kaplan A, Casale T (2013) Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. N Engl J Med 368:924–935. doi:10.1056/NEJMoa1215372

    Article  CAS  PubMed  Google Scholar 

  112. Aubin F, Avenel-Audran M, Jeanmougin M, Adamski H, Peyron JL, Marguery MC, Léonard F, Puyraveau M, Viguier M; Société Française de Photodermatologie (2016) Omalizumab in patients with severe and refractory solar urticaria: a phase II multicentric study. J Am Acad Dermatol 74:574–575. doi: 10.1016/j.jaad.2015.11.021

  113. Chicharro P, Rodríguez P, de Argila D (2016) Omalizumab in the treatment of chronic inducible urticaria. Actas Dermosifiliogr. doi:10.1016/j.ad.2016.07.018

  114. Kaplan A, Ferrer M, Bernstein JA, Antonova E, Trzaskoma B, Raimundo K, Rosén K, Omachi TA, Khalil S, Zazzali JL (2015) Timing and duration of omalizumab response in patients with chronic idiopathic/spontaneous urticaria. J Allergy Clin Immunol 137:474–481. doi:10.1016/j.jaci.2015.08.023

    Article  PubMed  CAS  Google Scholar 

  115. Maurer M, Sofen H, Ortiz B, Kianifard F, Gabriel S, Bernstein JA (2016) Positive impact of omalizumab on angioedema and quality of life in patients with refractory chronic idiopathic/spontaneous urticaria: analyses according to the presence or absence of angioedema. J Eur Acad Dermatol Venereol. doi:10.1111/jdv.14075

  116. Gericke J, Metz M, Ohanyan T, Weller K, Altrichter S, Skov PS, Falkencrone S, Brand J, Kromminga A, Hawro T, Church MK, Maurer M (2016) Serum autoreactivity predicts time to response to omalizumab therapy in chronic spontaneous urticaria. J Allergy Clin Immunol 139:1059–1061. doi:10.1016/j.jaci.2016.07.047

    Article  PubMed  CAS  Google Scholar 

  117. Bongiorno MR, Crimi N, Corrao S, Allotta A, Arena A, Brusca I, Heffler E, Malara G, Milioto M, Pistone G, Porto M, Raia E, Valenti G (2016) Omalizumab for the treatment of chronic spontaneous urticaria in clinical practice. Ann Allergy Asthma Immunol 117:703–707. doi:10.1016/j.anai.2016.08.006

    Article  CAS  PubMed  Google Scholar 

  118. Metz M, Ohanyan T, Church MK, Maurer M (2014) Retreatment with omalizumab results in rapid remission in chronic spontaneous and inducible urticaria. JAMA Dermatol 150:288e290. doi:10.1016/j.jdermsci.2013.08.011

    Article  CAS  Google Scholar 

  119. Sussman G, Hébert J, Barron C, Bian J, Caron-Guay RM, Laflamme S, Stern S (2014) Real-life experiences with omalizumab for the treatment of chronic urticaria. Ann Allergy Asthma Immunol 112:170–174. doi:10.1016/j.anai.2013.12.005

    Article  CAS  PubMed  Google Scholar 

  120. Vestergaard C, Toubi E, Maurer M, Triggiani M, Ballmer-Weber B, Marsland A, Ferrer M, Knulst A, Giménez-Arnau A (2017) Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamines: an expert opinion. Eur J Dermatol 27:10–19. doi:10.1684/ejd.2016.2905

    PubMed  Google Scholar 

  121. Seth S, Khan DA (2017) The comparative safety of multiple alternative agents in refractory chronic urticaria patients. J Allergy Clin Immunol Pract 5:165–170. doi:10.1016/j.jaip.2016.08.010

    Article  PubMed  Google Scholar 

  122. Sand FL, Thomsen SF (2015) Off-label use of TNF-alpha inhibitors in a dermatological university department: retrospective evaluation of 118 patients. Dermatol Ther 28:158–165. doi:10.1111/dth.12222

    Article  PubMed  Google Scholar 

  123. Kocatürk E, Maurer M, Metz M, Grattan C (2017) Looking forward to new targeted treatments for chronic spontaneous urticaria. Clin Transl Allergy 7:1. doi:10.1186/s13601-016-0139-2

    Article  PubMed  PubMed Central  Google Scholar 

  124. Arm JP, Bottoli I, Skerjanec A, Floch D, Groenewegen A, Maahs S, Owen CE, Jones I, Lowe PJ (2014) Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high-affinity anti-IgE antibody, in atopic subjects. Clin Exp Allergy 44(11):1371–1385. doi:10.1111/cea.12400

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  125. Harris JM, Cabanski CR, Scheerens H, Samineni D, Bradley MS, Cochran C, Staubach P, Metz M, Sussman G, Maurer M (2016) A randomized trial of quilizumab in adults with refractory chronic spontaneous urticaria. J Allergy Clin Immunol 138:1730–1732. doi:10.1016/j.jaci.2016.06.023

    Article  PubMed  Google Scholar 

  126. Dubois EA, Rissmann R, Cohen AF (2011) Rilonacept and canakinumab. Br J Clin Pharmacol 71(5):639–641. doi:10.1111/j.1365-2125.2011.03958.x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  127. Thorp WA, Goldner W, Meza J, Poole JA (2010) Reduced vitamin D levels in adult subjects with chronic urticaria. J Allergy Clin Immunol 126:413. doi:10.1016/j.jaci.2010.04.040

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, 3010, Bern, Switzerland

    Susanne Radonjic-Hoesli & Dagmar Simon

  2. Department of Dermatology, Allergy Unit, University Hospital Basel, 4031, Basel, Switzerland

    Kathrin Scherer Hofmeier & Andreas Bircher

  3. Department of Dermatology and Allergy, University Hospital Zurich, 8091, Zurich, Switzerland

    Sara Micaletto & Peter Schmid-Grendelmeier

Authors
  1. Susanne Radonjic-Hoesli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kathrin Scherer Hofmeier
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sara Micaletto
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Peter Schmid-Grendelmeier
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Andreas Bircher
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Dagmar Simon
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Susanne Radonjic-Hoesli or Dagmar Simon.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Funding

None.

Research Involving Human Participants and/or Animals

Not applicable.

Ethical Approval and Informed Consent

Not applicable.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Radonjic-Hoesli, S., Hofmeier, K.S., Micaletto, S. et al. Urticaria and Angioedema: an Update on Classification and Pathogenesis. Clinic Rev Allerg Immunol 54, 88–101 (2018). https://doi.org/10.1007/s12016-017-8628-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12016-017-8628-1

Keywords

Search

Navigation